Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 5—May 2024
Research

Identifying Contact Time Required for Secondary Transmission of Clostridioides difficile Infections by Using Real-Time Locating System

Min Hyung Kim, Jaewoong Kim, Heejin Ra, Sooyeon Jeong, Yoon Soo Park, Dongju Won, Hyukmin Lee1, and Heejung Kim1Comments to Author 
Author affiliations: Hallym University Dongtan Sacred Heart Hospital, Hwasieong, South Korea (M.H. Kim); Yonsei University College of Medicine, Seoul, South Korea (J. Kim, D. Won, H. Lee); Yonsei University Yongin Severance Hospital, Yongin, South Korea (H. Ra, S. Jeong, Y.S. Park, H. Kim)

Main Article

Table 1

Baseline characteristics of patients in study identifying contact time required for secondary transmission of Clostridioides difficile infections by using real-time locating system in South Korea*

Characteristics All patients Patients with subsequent CDI
Patients without subsequent CDI p value‡
Secondary transmission Nonsecondary transmission p value†
Total no. patients 2,520 2 56 NA 2,462 NA
Mean age, y (SD)
60.4 (19.8)
81.5 (2.1)
73.4 (11.6)
<0.001
60.06 (19.80)
0.091
Sex
M 1,343 (53.3) 2 (100.0) 31 (55.4) >0.99 1,310 (53.2) NA
F
1,177 (46.7)
NA
NA
NA
NA
NA
Prior hospitalization 381 (15.1) 0 18 (32.1) >0.99 263 (14.7) 0.153
Recent antimicrobials
1,686 (66.9)
2 (100.0)
54 (96.4)
>0.99
1,630 (66.2)
0.047
Underlying conditions
Diabetes mellitus 765 (30.4) 1 (50.0) 25 (44.6) 0.881 739 (30.0) 0.600
COPD 91 (3.6) 0 6 (10.7) >0.99 85 (3.5) 0.926
Chronic heart failure 617 (24.5) 1 (50.0) 28 (50.0) >0.99 588 (23.9) 0.876
Hypertension 1,131 (44.9) 1 (50.0) 36 (64.3) 0.683 1,094 (44.4) 0.521
Chronic kidney disease 341 (13.5) 0 18 (32.1) >0.99 323 (13.1) 0.633
Malignancy 640 (25.4) 1 (50.0) 21 (37.5) 0.723 618 (25.1) 0.905
IBD 1 (0.0) 0 0 NA 1 (0.0) NA
CVA 279 (11.1) 0 11 (19.6) >0.99 268 (10.9) NA
HSCT
104 (4.1)
0
8 (14.3)
>0.99
96 (3.9)
0.821
Median CCI score (IQR) 2 (0–3) 2.5 (2.25–2.75) 4 (2–6) 0.447 2 (0–4) 0.387
No. days before index patient treatment, median (IQR)
1 (0–2)
1.5 (1.25–1.75)
1 (0–2)
>0.99
1 (0–2)
NA
Laboratory tests
Blood leukocyte count >15,000/µL 244 (11.2) 0 12 (22.2) >0.99 232 (10.9) 0.710
Median CRP, mg/L (IQR) 3.9 (0.6–34.7) 53.3 (44–62.6) 42.9 (16.3–93.2) 0.794 4.8 (0.7–40.4) 0.209
Mean albumin, g/dL (SD)
3.05 (0.54)
3.15 (0.35)
3.10 (0.55)
0.890
2.96 (0.55)
NA
Clinical conditions
Ileostomy 29 (1.2) 0 1 (1.8) >0.99 28 (1.1) NA
Enteral tube insertion 325 (12.9) 2 (100.0) 21 (37.5) >0.99 302 (12.3) 0.201
No. contact cases§
3,620
2
124

3,494

Group 1¶ 909 (25.1) 1 (50.0) 43 (34.7) >0.99 865 (24.7) 0.516
Room sharing# 181 (19.9) 0 11 (25.6) >0.99 170 (19.7) NA
Contact during diarrhea episode**
316 (34.8)
0
13 (30.2)
>0.99
303 (35.0)
NA
Group 2†† 421 (11.6) 0 11 (8.9) >0.99 410 (11.7) NA
Group 3‡‡ 2,290 (63.3) 1 (50.0) 70 (56.5) >0.99 2,219 (63.5) NA
Median contact time, min (IQR) 4,320 (131.5–8,640) 7,976.5 (4,044.75–11,908.25) 4,320 (133.25–10,080.0) 0.465 4,320 (132–8,640) NA
No. deaths 162 (6.4) 0 11 (19.6) >0.99 151 (6.1) NA

*Values are no. (%) except as indicated. CCI, Charlson comorbidity index; CDI, Clostridioides difficile infection; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; CVA, cerebrovascular accident; HSCT, hematopoietic stem cell transplantation; IBD, inflammatory bowel disease; IQR, interquartile range; NA, not applicable. †A univariate logistic regression was used to compute p values, comparing secondary transmission with nonsecondary transmission. ‡A generalized linear mixed model was used to compute p values after adjusting for variables exhibiting statistical significance in the univariate analysis; the model was used to elucidate the odds of subsequent CDI occurrence. The odds ratios and 95% CIs for each variable are shown in Appendix 1 Table 2. §Because 744 patients experienced >2 episodes of contact with separate index patients, a disparity emerged between the number of contact cases and the number of contact patients. ¶Group 1 included patients who had direct contact with index patients. #Co-hospitalization in the same bedroom with the index patient for >24 hours. **Contact with index patient who had diarrhea. ††Group 2 included patients who had indirect contact with index patients via healthcare personnel. ‡‡Group 3 included patients who had indirect contact with index patients via the environment.

Main Article

1These authors contributed equally to this article.

Page created: March 01, 2024
Page updated: April 23, 2024
Page reviewed: April 23, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external